<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Opko Health, Inc.

    Opko Health, Inc.

    OPKO Health, Inc. is a diversified healthcare company that seeks to serve unmet pa...

    OPKO Health, Inc. is a diversified healthcare c...

    Filing Type:    PU
    Restoration Robotics, Inc.

    Restoration Robotics, Inc.

    Restoration Robotics, Inc., (San Jose, CA) is a medical device company developing ...

    Restoration Robotics, Inc., (San Jose, CA) is a...

    Filing Type:    PU
    Acceleron Pharma Inc.

    Acceleron Pharma Inc.

    Acceleron is dedicated to the discovery and development of innovative, life-changi...

    Acceleron is dedicated to the discovery and dev...

    Filing Type:    PU
    Alnylam Pharmaceuticals, Inc.

    Alnylam Pharmaceuticals, Inc.

    Alnylam is leading the translation of RNA interference (RNAi) into a whole new cla...

    Alnylam is leading the translation of RNA inter...

    Filing Type:    PU
    uniQure N.V.

    uniQure N.V.

    uniQure is delivering on the promise of gene therapy -- single treatments with pot...

    uniQure is delivering on the promise of gene th...

    Filing Type:    PU
    Calithera Biosciences, Inc.

    Calithera Biosciences, Inc.

    Calithera is a clinical-stage biopharmaceutical company pioneering the discovery a...

    Calithera is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Veru Inc.

    Veru Inc.

    Our strategy is to be known as “the prostate cancer company”. We aspire to be ...

    Our strategy is to be known as “the prostate ...

    Filing Type:    PU
    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focused...

    SELLAS Life Sciences Group, Inc. is a late-stag...

    Filing Type:    PU
    Agios Pharmaceuticals, Inc.

    Agios Pharmaceuticals, Inc.

    Agios is a biopharmaceutical company passionately committed to applying our scient...

    Agios is a biopharmaceutical company passionate...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.